Description
N-Acetyl Semax Amidate Nasal Spray
| Semax | |
| CAS Number | 4037-01-8 |
| Molar Mass | 813.93 g·mol−1 |
| Chemical Formula | C37H51N9O10S |
| IUPAC Name | (2S)-1-[2-{[(2S)-1-[(2S)-2-{[2-{[(2S)-2-{[(2S)-2-amino-4-methylsulfanylbutanoyl]amino}-4-carboxybutanoyl]amino}-3-(1H-imidazol-5-yl)propanoyl]amino}-3-phenylpropanoyl]pyrrolidine-2-carbonyl]amino}acetyl]pyrrolidine-2-carboxylic acid |
N-Acetyl Semax Amidate is a synthetic peptide derivative designed for research purposes only. It is a modified version of Semax, a nootropic peptide originally developed for cognitive enhancement and neuroprotective properties. This advanced formulation, N-Acetyl Semax Amidate, aims to explore potential applications in various research areas.
Key Characteristics
N-Acetyl Semax Amidate is a modified peptide with an amidated structure for enhanced stability. Designed to interact with neural receptors, particularly those associated with dopamine regulation and cognitive function.
Research Applications
N-Acetyl Semax Amidate is intended for investigation into its effects on neurotransmitter pathways, specifically dopamine regulation. Additionally, it is also used to investigate its potential applications in addressing cognitive disorders and attention-related conditions.
Potential Benefits
Semax and Dopamine
Research suggests that Semax may modulate dopamine levels in the brain, influencing mood, motivation, and cognitive processes.
Semax and ADHD
Preliminary studies indicate that Semax might exhibit properties beneficial for individuals with attention deficit hyperactivity disorder (ADHD).
Semax and Memory
Ongoing research explores the potential of Semax in enhancing memory and cognitive functions.
Disclaimer
This site provides educational content, not medical advice. The substances discussed are for laboratory and research use only. Clinical studies need IRB oversight, and preclinical research must follow Animal Care and Use Committee (IACUC) guidelines, following the Animal Welfare Act (AWA).
Upon the finalization of your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer contentment stands as our paramount concern. Should you find any dissatisfaction with the product received, kindly contact us at 419-707-5450 or email our support team at [email protected].
ATTENTION: BC9 products are strictly for LABORATORY AND RESEARCH PURPOSES ONLY, not for human or veterinary use.
References
- Eremin KO, Kudrin VS, Saransaari P, Oja SS, Grivennikov IA, Myasoedov NF, Rayevsky KS. Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents. Neurochem Res. 2005 Dec;30(12):1493-500. doi: 10.1007/s11064-005-8826-8. PMID: 16362768. [Read More].
- Shih-Jen Tsai, Semax, an analogue of adrenocorticotropin (4–10), is a potential agent for the treatment of attention-deficit hyperactivity disorder and Rett syndrome, Medical Hypotheses, Volume 68, Issue 5, 2007, Pages 1144-1146, ISSN 0306-9877, https://doi.org/10.1016/j.mehy.2006.07.017. [Read More].
- Asmarin IP, Nezavibat’ko VN, Miasoedov NF, Kamenskiĭ AA, Grivennikov IA, Ponomareva-Stepnaia MA, Andreeva LA, Kaplan AIa, Koshelev VB, Riasina TV. Nootropnyĭ analog adrenokortikotropina 4-10-semaks (15-letniĭ opyt razrabotki i izucheniia) [A nootropic adrenocorticotropin analog 4-10-semax (l5 years experience in its design and study)]. Zh Vyssh Nerv Deiat Im I P Pavlova. 1997 Mar-Apr;47(2):420-30. Russian. PMID: 9173745. [Read More].
Eva –
It’s noticeably enhanced my cognitive function and mental clarity.